Home › Heart Valve Diseases › Oregon › Portland
Heart Valve Diseases clinical trials in Portland, OR
3 studies for Heart Valve Diseases are looking for participants at sites in and around Portland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Recruiting
- Providence Saint Vincent Medical Center, Portland
- Oregon Health & Science University Hospital, Portland
Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment
RecruitingObservational study
- Providence St. Vincent Medical Center, Portland
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Recruiting
- Oregon Health & Science University (OHSU), Portland
- Providence Heart Institute, Portland
About Heart Valve Diseases
Heart valve disease happens when one or more of your heart valves do not open or close correctly. This can affect your blood flow and strain your heart.
More about Heart Valve Diseases on MedlinePlus
Heart Valve Diseases trials in other cities
- New York City, NY11 studies
- Cleveland, OH10 studies
- Chicago, IL5 studies
- Cincinnati, OH5 studies
- Minneapolis, MN5 studies
- Phoenix, AZ5 studies
- Atlanta, GA4 studies
- Houston, TX4 studies
- Pittsburgh, PA4 studies
- Boston, MA4 studies
- Philadelphia, PA4 studies
- Thousand Oaks, CA3 studies
Other studies in Portland
- Non-Small Cell Lung Cancer46 studies
- Cancer (all types)34 studies
- Breast Cancer33 studies
- Prostate Cancer33 studies
- Metastatic Cancer29 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Lung Cancer26 studies
- Acute Myeloid Leukemia25 studies
- Endometrial Cancer24 studies
- Head and Neck Squamous Cell Carcinoma19 studies
- Pancreatic Cancer19 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.